Repligen | RGEN - Bénéfice Avant Impôts





Bénéfice Avant Impôts Changement Date
Agilent USD 442M 1000K 2025-09
Align Technology USD 148.89M 27.71M 2026-03
Bio Techne USD 84.99M 107.85M 2025-09
BioMarin Pharmaceutical USD 141.2M 168.36M 2026-03
Bristol-Myers Squibb USD 1.47B 1.64B 2025-12
Bruker USD -72.6M 73.1M 2025-09
Charles River Laboratories USD 170.03M 98.62M 2025-09
Danaher USD 1.24B 138M 2026-03
Dentsply International USD -147M 83M 2025-12
General Electric Aerospace USD 2.2B 654M 2026-03
Henry Schein USD 133M 4M 2025-12
Illumina USD 157M 220M 2026-03
IQVIA Holdings USD 6.22B 5.68B 2026-03
Mettler Toledo International USD 269.24M 20.58M 2025-09
Myriad Genetics USD 4.6M 3.4M 2025-12
OraSure Technologies USD -18.43M 5.14M 2025-12
Pacific Biosciences Of California USD -40.17M 2.55M 2025-12
Pfizer USD 5.18B 6.82B 2026-03
Repligen USD 19.11M 2M 2025-12
Revvity USD 91.56M 35.88M 2025-12
Standard Biotools USD -22.03M 10.87M 2025-12
Thermo Fisher Scientific USD 2.12B 295M 2025-12
Waters USD 264.18M 94.06M 2025-12
West Pharmaceutical Services USD 161.5M 8.6M 2025-12